Springbank 18
Selected indexed studies
- Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. (Lancet Glob Health, 2022) [PMID:35063115]
- A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. (Nat Rev Gastroenterol Hepatol, 2022) [PMID:35859026]
- Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. (JHEP Rep, 2025) [PMID:39980749]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. (2022) pubmed
- Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. (2023) pubmed
- A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. (2022) pubmed
- Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. (2025) pubmed
- Development and Validation of a High-Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA Detection. (2025) pubmed
- Impact of tobacco and/or nicotine products on health and functioning: a scoping review and findings from the preparatory phase of the development of a new self-report measure. (2021) pubmed
- Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction. (2022) pubmed
- Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection. (2022) pubmed
- Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181). (2021) pubmed
- Detection of the Hepatitis B Surface Antigen in Patients with Occult Hepatitis B by Use of an Assay with Enhanced Sensitivity. (2022) pubmed